PDP1 and heart failure: TMZ is often defined a “metabolic modulator” due to its ability to improve energy metabolism in heart failure; it reduces fatty acid metabolism through the inhibition of the enzyme ACAA2 and by enhancing glucose metabolism through the activation of the rate-limiting enzyme Pyruvate Dehydrogenase (PDH), involved in glucose aerobic oxidation [24,40].